Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 1
1998 1
1999 1
2001 2
2002 1
2003 1
2006 1
2007 4
2008 2
2009 3
2010 2
2014 1
2015 2
2016 2
2020 2
2021 3
2022 3
2023 3
2024 3
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, Polack FP, Llapur C, Doreski PA, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Castillo Villa G, Ingilizova M, Eiras D, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gurtman A, Gruber WC, Schmoele-Thoma B; RENOIR Clinical Trial Group. Walsh EE, et al. Among authors: ilangovan k. N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5. N Engl J Med. 2023. PMID: 37018468 Clinical Trial.
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
Walsh EE, Pérez Marc G, Falsey AR, Jiang Q, Eiras D, Patton M, Polack FP, Llapur C, Doreski PA, Zareba AM, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gruber WC, Schmoele-Thoma B, Gurtman A. Walsh EE, et al. Among authors: ilangovan k. N Engl J Med. 2024 Oct 17;391(15):1459-1460. doi: 10.1056/NEJMc2311560. N Engl J Med. 2024. PMID: 39413383 No abstract available.
Efficacy, Immunogenicity, and Safety of the Bivalent RSV Prefusion F (RSVpreF) Vaccine in Older Adults Over 2 RSV Seasons.
Walsh EE, Eiras D, Woodside J, Jiang Q, Patton M, Marc GP, Llapur C, Rämet M, Fukushima Y, Hussen N, Cardona J, Mikati T, Zareba A, Ilangovan K, Lino MM, Kalinina EV, Swanson KA, Gurtman A, Munjal I. Walsh EE, et al. Among authors: ilangovan k. Clin Infect Dis. 2025 Feb 10:ciaf061. doi: 10.1093/cid/ciaf061. Online ahead of print. Clin Infect Dis. 2025. PMID: 39928572
2,5-Dimethyl-1-phenyl-sulfonyl-1H-pyrrole-3,4-dicarbaldehyde.
Seshadri PR, Balakrishnan B, Ilangovan K, Sureshbabu R, Mohanakrishnan AK. Seshadri PR, et al. Among authors: ilangovan k. Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 18;65(Pt 3):o531. doi: 10.1107/S1600536809004425. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21582192 Free PMC article.
Expression of recombinant proteins in Pichia pastoris.
Li P, Anumanthan A, Gao XG, Ilangovan K, Suzara VV, Düzgüneş N, Renugopalakrishnan V. Li P, et al. Among authors: ilangovan k. Appl Biochem Biotechnol. 2007 Aug;142(2):105-24. doi: 10.1007/s12010-007-0003-x. Appl Biochem Biotechnol. 2007. PMID: 18025573 Review.
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.
Almeida NC, Parameswaran L, DeHaan EN, Wyper H, Rahman F, Jiang Q, Li W, Patton M, Lino MM, Majid-Mahomed Z, Malkin E, Davis M, Towner WJ, Saharia K, Ilangovan K, Kalinina E, Cooper D, Swanson KA, Anderson AS, Gurtman A, Munjal I. Almeida NC, et al. Among authors: ilangovan k. Vaccines (Basel). 2025 Mar 19;13(3):328. doi: 10.3390/vaccines13030328. Vaccines (Basel). 2025. PMID: 40266222 Free PMC article.
Ethyl 2-[N-(2-Formyl-phen-yl)benzene-sulfonamido]acetate.
Seshadri PR, Balakrishnan B, Ilangovan K, Sureshbabu R, Mohanakrishnan AK. Seshadri PR, et al. Among authors: ilangovan k. Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 18;65(Pt 3):o530. doi: 10.1107/S1600536809004413. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21582191 Free PMC article.
Surveillance for face mask compliance, Chennai, Tamil Nadu, India, October-December, 2020.
M J, Rubeshkumar P, Raju M, Sakthivel M, Murali S, Nagarajan R, Sendhilkumar M, Sambath I, Ilangovan K, Harikrishnan D, Venkatasamy V, Ganeshkumar P, Reddy M, Kaur P. M J, et al. Among authors: ilangovan k. PLoS One. 2021 Sep 24;16(9):e0257739. doi: 10.1371/journal.pone.0257739. eCollection 2021. PLoS One. 2021. PMID: 34559845 Free PMC article.
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.
Christensen S, Bouguermouh S, Ilangovan K, Pride MW, Webber C, Lockhart SP, Shah R, Kitchin N, Lamberth E, Zhang H, Gao Q, Brock L, Anderson AS, Gruber WC. Christensen S, et al. Among authors: ilangovan k. Vaccine. 2023 Dec 7;41(50):7548-7559. doi: 10.1016/j.vaccine.2023.11.003. Epub 2023 Nov 17. Vaccine. 2023. PMID: 37977942 Free article. Clinical Trial.
43 results